New Key Statistics Module, Z-Score and F-Score
NAS:MRKR Key Ratios
| Market Cap $ M | 36.55 |
| Enterprise Value $ M | 19.05 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 2.59 |
| Price/Sales | 10.23 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 3.00 |
| EPS (TTM) $ | -0.94 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | 40.60 |
| 5-y EBITDA Growth Rate % | 46.00 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.24 |
| EV-to-EBITDA | -1.33 |
| PEG | -- |
| Shares Outstanding M | 8.91 |
| Net Margin (%) | -235.34 |
| Operating Margin % | -437.83 |
| Pre-tax Margin (%) | -422.43 |
| Quick Ratio | 5.57 |
| Current Ratio | 5.57 |
| ROA % (ttm) | -34.06 |
| ROE % (ttm) | -48.28 |
| ROIC % (ttm) | -181.06 |
| Dividend Yield % | -- |
| Altman Z-Score | -30.07 |
MRKR Number of Guru Trades
MRKR Volume of Guru Trades
Gurus Latest Trades with NAS:MRKR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:MRKR is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Marker Therapeutics Inc Insider Transactions
No Available Data
News about NAS:MRKR
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers